Mounjaro, a relatively new drug approved by the FDA in May 2023, is generating significant excitement within the medical community for its potential to treat Type 2 diabetes. While not a cure, Mounjaro appears to be providing substantial results in managing blood sugar levels and decreasing the need for other medications. Early studies show promisi